Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TAST
4401
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $55.2K | ﹤0.01% |
+10,944
| New | +$49.6K |
|
|
KZR
4402
DELISTED
Kezar Life Sciences
KZR
| $55.1K | ﹤0.01% |
2,249
-17,770
| -89% | -$463K |
|
|
MCHB
4403
Mechanics Bancorp
MCHB
$3.51B
| $54.9K | ﹤0.01% |
9,266
-2,380
| -20% | -$22.3K |
|
4404
ReNew
RNW
$2.22B
| $54.8K | ﹤0.01% |
+10,000
| New | +$54.7K |
|
4405
State Street SPDR Dow Jones REIT ETF
RWR
$1.91B
| $54.7K | ﹤0.01% |
605
-411
| -40% | -$36.3K |
|
4406
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $54.7K | ﹤0.01% |
2,116
| – | – |
|
|
CCRD
4407
DELISTED
CoreCard
CCRD
| $54.7K | ﹤0.01% |
2,156
-24,625
| -92% | -$635K |
|
|
PAMT
4408
PAMT Corp
PAMT
$360M
| $54.4K | ﹤0.01% |
2,032
+1,666
| +455% | +$42.6K |
|
4409
Douglas Elliman
DOUG
$160M
| $54.2K | ﹤0.01% |
24,433
-12,227
| -33% | -$33.6K |
|
|
PHLT
4410
DELISTED
Performant Healthcare Inc
PHLT
| $54.1K | ﹤0.01% |
20,044
-46,473
| -70% | -$135K |
|
4411
Alico
ALCO
$284M
| $54.1K | ﹤0.01% |
2,125
+2,105
| +10,525% | +$51.2K |
|
|
GRTS
4412
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $53.9K | ﹤0.01% |
27,647
-154,818
| -85% | -$363K |
|
4413
OR Royalties Inc
OR
$5.52B
| $53.9K | ﹤0.01% |
3,500
-1,500
| -30% | -$24.3K |
|
4414
Blue Ridge Bankshares
BRBS
$322M
| $53.8K | ﹤0.01% |
6,075
+6,028
| +12,826% | +$54.6K |
|
4415
Nature's Sunshine
NATR
$365M
| $53.6K | ﹤0.01% |
3,928
+3,927
| +392,700% | +$44.7K |
|
4416
ALX Oncology
ALXO
$268M
| $53.6K | ﹤0.01% |
7,139
+6,214
| +672% | +$40.7K |
|
4417
Tango Therapeutics
TNGX
$4.34B
| $53.5K | ﹤0.01% |
16,128
+7,937
| +97% | +$28.6K |
|
4418
Purple Innovation
PRPL
$35.7M
| $53.2K | ﹤0.01% |
765
+697
| +1,025% | +$50.2K |
|
4419
Amplify Online Retail ETF
IBUY
$113M
| $53.2K | ﹤0.01% |
1,150
| – | – |
|
|
ITIC
4420
Investors Title Co
ITIC
$549M
| $53.1K | ﹤0.01% |
364
+363
| +36,300% | +$51.4K |
|
4421
Parke Bancorp
PKBK
$400M
| $53.1K | ﹤0.01% |
3,126
+3,124
| +156,200% | +$52.4K |
|
4422
Ponce Financial Group
PDLB
$496M
| $52.9K | ﹤0.01% |
6,091
-57,588
| -90% | -$449K |
|
4423
Zevra Therapeutics
ZVRA
$575M
| $52.7K | ﹤0.01% |
10,332
-48,164
| -82% | -$260K |
|
|
KLRS
4424
Kalaris Therapeutics
KLRS
$79.5M
| $52.7K | ﹤0.01% |
674
+563
| +507% | +$53.5K |
|
|
VST.WS.A
4425
CALL
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
| $52.7K | ﹤0.01% |
877,894
| – | – |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.